Synthetic approaches to 1,2,4-triazolo[5,1-c][1,2,4]triazin-7-ones as basic heterocyclic structures of the antiviral drug Riamilovir (“Triazavirin®”) active against SARS-CoV-2 (COVID-19)Review article Published on 2022-01-262022-10-05 Journal: Organic & Biomolecular Chemistry [Category] 치료제, [키워드] active against antiviral drug approach biological activities Compound COVID-19 derivative fragment information Riamilovir SARS-CoV-2 Structure synthetic [DOI] 10.1039/d1ob02125g [Article Type] Review article
The efficacy of triazavirin (riamilovir)-based treatment for coronavirus disease 2019 (COVID-19) in clinical trials and preliminary practical experiencesReview Published on 2022-01-012023-07-11 Journal: Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a [Category] COVID19(2023년), [키워드] clinical trials COVID-19 practical experiences Riamilovir SARS-CoV-2 triazavirin [Article Type] Review